HCPCS Level II › J
HCPCS Level II codes starting with J
1,255 codes, page 10 of 13. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| J7500 | Azathioprine, oral, 50 mg | Valid |
| J7501 | Azathioprine, parenteral, 100 mg | Valid |
| J7502 | Cyclosporine, oral, 100 mg | Valid |
| J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | Valid |
| J7504 | Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg | Valid |
| J7505 | Muromonab-cd3, parenteral, 5 mg through FY2026 | Terminated |
| J7506 | Prednisone, oral, per 5 mg through FY2026 | Terminated |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | Valid |
| J7508 | Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg | Valid |
| J7509 | Methylprednisolone oral, per 4 mg | Valid |
| J7510 | Prednisolone oral, per 5 mg | Valid |
| J7511 | Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg | Valid |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | Valid |
| J7513 | Daclizumab, parenteral, 25 mg through FY2026 | Terminated |
| J7514 | Mycophenolate mofetil (myhibbin), oral suspension, 100 mg through FY2026 | Terminated |
| J7515 | Cyclosporine, oral, 25 mg | Valid |
| J7516 | Injection, cyclosporine, 250 mg | Valid |
| J7517 | Mycophenolate mofetil, oral, 250 mg through FY2026 | Terminated |
| J7518 | Mycophenolic acid, oral, 180 mg | Valid |
| J7519 | Injection, mycophenolate mofetil, 10 mg through FY2026 | Terminated |
| J7520 | Sirolimus, oral, 1 mg | Valid |
| J7521 | Tacrolimus, granules, oral suspension, 0.1 mg | Valid |
| J7524 | Mycophenolate mofetil, oral, 5 mg | Valid |
| J7525 | Tacrolimus, parenteral, 5 mg | Valid |
| J7526 | Injection, mycophenolate mofetil, 5 mg | Valid |
| J7527 | Everolimus, oral, 0.25 mg | Valid |
| J7528 | Mycophenolate mofetil, for suspension, oral, 100 mg through FY2026 | Terminated |
| J7529 | Mycophenolate mofetil, for suspension, oral, 5 mg | Valid |
| J7530 | Mycophenolate mofetil (myhibbin), oral suspension, 5 mg | Valid |
| J7531 | Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg | Valid |
| J7599 | Immunosuppressive drug, not otherwise classified | Valid |
| J7601 | Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg | Valid |
| J7604 | Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram | Valid |
| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms | Valid |
| J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms | Valid |
| J7607 | Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg | Valid |
| J7608 | Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram | Valid |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | Valid |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | Valid |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | Valid |
| J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | Valid |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Valid |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | Valid |
| J7615 | Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg | Valid |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Valid |
| J7622 | Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Valid |
| J7624 | Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Valid |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | Valid |
| J7627 | Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg | Valid |
| J7628 | Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Valid |
| J7629 | Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Valid |
| J7631 | Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams | Valid |
| J7632 | Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams | Valid |
| J7633 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram | Valid |
| J7634 | Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram | Valid |
| J7635 | Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Valid |
| J7636 | Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Valid |
| J7637 | Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Valid |
| J7638 | Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Valid |
| J7639 | Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | Valid |
| J7640 | Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms | Valid |
| J7641 | Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram | Valid |
| J7642 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Valid |
| J7643 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Valid |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | Valid |
| J7645 | Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Valid |
| J7647 | Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Valid |
| J7648 | Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram | Valid |
| J7649 | Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | Valid |
| J7650 | Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Valid |
| J7657 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Valid |
| J7658 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram | Valid |
| J7659 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | Valid |
| J7660 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Valid |
| J7665 | Mannitol, administered through an inhaler, 5 mg | Valid |
| J7667 | Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams | Valid |
| J7668 | Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams | Valid |
| J7669 | Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams | Valid |
| J7670 | Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams | Valid |
| J7674 | Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg | Valid |
| J7676 | Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg | Valid |
| J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram | Valid |
| J7680 | Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Valid |
| J7681 | Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Valid |
| J7682 | Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams | Valid |
| J7683 | Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Valid |
| J7684 | Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Valid |
| J7685 | Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams | Valid |
| J7686 | Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg | Valid |
| J7699 | Noc drugs, inhalation solution administered through dme | Valid |
| J7799 | Noc drugs, other than inhalation drugs, administered through dme | Valid |
| J7999 | Compounded drug, not otherwise classified | Valid |
| J8498 | Antiemetic drug, rectal/suppository, not otherwise specified | Valid |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | Valid |
| J8501 | Aprepitant, oral, 5 mg | Valid |
| J8502 | Injection, aprepitant (aponvie), 1 mg | Valid |
| J8510 | Busulfan; oral, 2 mg | Valid |
| J8515 | Cabergoline, oral, 0.25 mg | Valid |
| J8520 | Capecitabine, oral, 150 mg through FY2026 | Terminated |
| J8521 | Capecitabine, oral, 500 mg through FY2026 | Terminated |